GMP Factory Supply High Assay Pharmaceutical Raw Material Ox Bile Powder Good Price

• Certification: ISO
• Storage Method: Normal
• Extraction Process: Physical
• Application: Food, Health Care Products, Medicine
• State: Powder
• Extract Source: Cow
• Model NO.: powder
• Bile Acid Content: Nlt 45%
• Transport Package: 25kg/Drum
• Specification: 25kg/Drum
• Trademark: HD
• Origin: China
• Production Capacity: 50000kg/Month

Product Description

Ox bile extract powder, derived from ox bile, is a natural product with a wide range of applications. It contains essential components such as bile acids, cholesterol, bilirubin, and fatty acids. Through meticulous preparation processes, it is transformed into a powdered form, enhancing its stability and convenience. Ox bile extract powder exhibits diverse applications in the fields of pharmaceuticals, the food industry, and scientific research. 
Ox bile extract powder is a yellow to brownish powder obtained from the bile of oxen. It is processed through a series of steps, starting with the collection of ox bile, followed by purification and concentration. The subsequent conversion of the bile into a powdered form enhances its stability and ease of use. Rigorous quality control ensures the purity and quality of the final product. Ox bile extract powder is carefully manufactured to preserve its natural properties and active components, making it a valuable ingredient for various applications.

Huadi Group is a national high-tech enterprise. It is invested and established by a group of professionals who are specialized in the R&D of the biopharmaceutical field and have rich experience in production management and operation. It is a group company that invests in the production of diversified industries such as pharmaceuticals, medical devices, food, health products, cosmetics, and biological agriculture products.

Huadi Group has a total of 8 subsidiaries: Zhejiang Huadi Pharmaceutical Group Co., Ltd., Hangzhou Huajin Pharmaceutical Co., Ltd., Zhejiang Huajun Pharmaceutical Co., Ltd., Zhejiang Huadi Pharmaceutical Group Pharmaceutical Development Co., Ltd., Hangzhou Huadi Health Technology Co., Ltd., Leizhou Huadi Biotechnology Co., Ltd., Hainan Huadi Pharmaceutical Co., Ltd., Hunan Huadi Biotechnology Co., Ltd.

Huadi Group is the vice president unit of the China Biochemical Pharmaceutical Industry Association and the vice president unit of the Zhejiang Health Industry Research Association. Its controlling subsidiary, Zhejiang Huadi Pharmaceutical Group, is the drafting unit of the GMP appendix for biochemical drugs of the National Good Manufacturing Practice for Drugs. The group has two provincial-level R&D centers, the Chief Scientist is a senior scientist and overseas returnee PhD from a fortune 500 company in the United States. The company has long hired domestic and foreign experts and scholars as technical consultants, with strong technological innovation capabilities. With nearly 30 years of R&D and industrial transformation experience in biochemical extraction products, multi-component biochemical drugs, and synthetic peptide products, the technical level is leading domestically; In 2019, the group jointly launched internationally leading biopharmaceutical cutting-edge projects with senior research teams from the United States and Zhejiang University: The preparation of medicinal proteins using plant instantaneous expression systems, and the personalized treatment of tumors - neoantigen peptide project. All of these projects have made breakthrough progress and their technical level is internationally leading.